Acne Vulgaris
3
Companies
9
Drug Programs
6
Phase 3
0
Upcoming PDUFAs
Galderma Group AG/ADR
CD5789 (trifarotene)
VYNE Therapeutics Inc.
Vehicle Foam
Galderma Group AG/ADR
Adapalene Lotion Vehicle
Galderma Group AG/ADR
CD0271
VYNE Therapeutics Inc.
FMX-101, 4% minocycline foam
VYNE Therapeutics Inc.
FMX101
VYNE Therapeutics Inc.
Topical Minocycline Foam FXFM244
VYNE Therapeutics Inc.
3% Minocycline Foam
Xenon Pharmaceuticals Inc.
XPF-005
| Company | Drug | Phase | Designations | Timeline | Trial ID |
|---|---|---|---|---|---|
| GALDY Galderma Group AG/ADR | CD5789 (trifarotene) | Phase 3 | — | — | — |
| VYNE VYNE Therapeutics Inc. | Vehicle Foam | Phase 3 | — | — | — |
| GALDY Galderma Group AG/ADR | Adapalene Lotion Vehicle | Phase 3 | — | — | — |
| GALDY Galderma Group AG/ADR | CD0271 | Phase 3 | — | — | — |
| VYNE VYNE Therapeutics Inc. | FMX-101, 4% minocycline foam | Phase 3 | — | — | — |
| VYNE VYNE Therapeutics Inc. | FMX101 | Phase 3 | — | — | — |
| VYNE VYNE Therapeutics Inc. | Topical Minocycline Foam FXFM244 | Phase 2 | — | — | — |
| VYNE VYNE Therapeutics Inc. | 3% Minocycline Foam | Phase 2 | — | — | — |
| XENE Xenon Pharmaceuticals Inc. | XPF-005 | Phase 2 | — | — | — |
Not Financial Advice
All predictions are probabilistic and based on historical data. Past performance does not guarantee future results. Consult a qualified financial advisor.